novo nordisk cuts prices for its glp-1 drugs. slashing weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus The GLP-1 weight loss drug

Route of Administration Analysis Subcutaneous Injectable Routes Dominate the GLP-1 Market

Case Study: The Role of Glucagon-Like Peptide-1 Receptor Agonists in Prompting a Meaningful Improvement in Alcohol Use Disorder

[DOI] [PubMed] [Google Scholar] 94.Abbass NJ, et al

Additionally, FGF7 and its receptor fibroblast growth factor receptor-2 (FGFR2), along with its various isoforms, are significantly linked to the progression risk in breast cancer cell lines [18]

July 2, 2025: UK Launches Pancreatitis Study for Patients Who Take Trulicity and Other GLP-1s In the United Kingdom, there has been a concerning increase in the number of patients who are going to the hospital and dying of pancreatitis after taking GLP-1s like Trulicity

Some preliminary animal studies and limited human research have explored whether allulose consumption might indirectly influence incretin hormone secretion, including GLP-1